EVT8683

Bristol Myers greenlights neurodegenerative medicine from Evotec pact for $20M
Fierce Biotech
Fri, 09/3/21 - 11:22 am
Evotec
Bristol-Myers Squibb
EVT8683
neurodegenerative disease